1. You Are At:
  2. Home
  3. India News
  4. Only 75 of 2,868 deaths during drug trials paid compensation

Only 75 of 2,868 deaths during drug trials paid compensation

New Delhi, Jul 24: With over 2,868 deaths taking place during clinical trials in the country since 2005, compensation has been paid in only 75 cases so far with the minimum amount being a meagre

PTI [ Updated: July 24, 2013 21:34 IST ]
only 75 of 2 868 deaths during drug trials paid compensation
only 75 of 2 868 deaths during drug trials paid compensation

New Delhi, Jul 24: With over 2,868 deaths taking place during clinical trials in the country since 2005, compensation has been paid in only 75 cases so far with the minimum amount being a meagre Rs 50,000 for a life lost.






Of the total deaths taking place during clinical trials of drugs, 89 cases - that is only 3 per cent - are attributable to ill-effects of drugs during such experiments.

According to Health Ministry data, companies have yet to pay compensation in 14 cases of death caused due to clinical trials of drugs, some of which are pending since 2005.

Drug companies participating in clinical trials of drugs in the country have paid compensation ranging from Rs 50,000 to a maximum of Rs 20 lakh since 2005 to those dying due to the adverse effects of drugs tried on them.

Though 436 people died during clinical trials in the country in 2012, only 16 were attributed directly to such experiments.

Of these, compensation has been paid in only 12 cases and for three others it is still under process.

While the minimum compensation of Rs 50,000 was paid by Sun Pharma for a life lost during such trials, the maximum of Rs 5.26 lakh was paid by Quintiles for another life lost.

According to data provided in the form of an affidavit by Union Health Secretary in a court this year, the ministry has admitted that around 11,972 serious adverse events (excluding death) were reported during the period from January 1, 2005 to June 30, 2012, out of which 506 events were found to be related to clinical trials.

Such cases were mainly related to cardiovascular, gastrointestinal, hepatic and renal-related problems.

Write a comment